Showing 1 - 20 results of 10,579 for search 'significantly ((altered decrease) OR (extended release))', query time: 0.39s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Viloxazine Extended-Release: A Review of in Attention-Deficit/Hyperactivity Disorder in Adults by Yahiya Y. Syed (6594444)

    Published 2025
    “…</p><p><br></p><p dir="ltr"><b>Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability</b> not applicable</p><p><br></p><p dir="ltr">Additional information about this Adis Drug Review can be found <a href="https://www.springer.com/gp/adis/products-services/adis-journals-newsletters/adis-drug-reviews" target="_blank">here</a></p><p><br></p><p dir="ltr"><b>Abstract</b></p><p dir="ltr">An extended-release once-daily oral capsule formulation of viloxazine (viloxazine ER; Qelbree®), a norepinephrine reuptake inhibitor and serotonin receptor modulator, has been approved in the USA for the treatment of attention-deficit/hyperactivity disorder (ADHD) in paediatric patients and adults. …”
  8. 8
  9. 9
  10. 10

    Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use by Hannah A. Blair (13864794)

    Published 2024
    “…</p> <p><br></p> <p>  </p> <p><strong>Abstract </strong>Sodium oxybate extended-release suspension (LUMRYZ™; hereafter referred to as sodium oxybate ER) represents a promising novel option for the treatment of narcolepsy. …”
  11. 11
  12. 12
  13. 13
  14. 14

    Effect of previous administration of extended-release buprenorphine (1 mg/kg SC) or saline in rats using a warm-water tail flick assay to assess acute thermal nociception. by Christina M. Larson (18196213)

    Published 2024
    “…A) Efficacy in response to standard buprenorphine at 1 mg/kg and 3 mg/kg was significantly decreased in rats previously exposed to extended-release buprenorphine (Bupe ER) vs. those exposed to saline. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20